Jordan J S VerPlank (Jordan Js VerPlank)

Years Active: 2020-2024
Publications (10 Years): 6

Harvard Medical School

SUNY Buffalo (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Harvard Medical School Jan 01 2017

United States

Post-doctoral fellow :: Cell Biology

Education History

SUNY Buffalo Sep 01 2011 - Dec 31 2016

United States

PHD :: Neuroscience

Publications

Jordan J S VerPlank, Joseph M Gawron, Nicholas J Silvestri, Lawrence Wrabetz, Maria Laura Feltri
Knockout of PA200 improves proteasomal degradation and myelination in a proteotoxic neuropathy. Life science alliance 7 (4) (2024)
Jordan J S VerPlank, Joseph M Gawron, Nicholas J Silvestri, Lawrence Wrabetz, Maria Laura Feltri
Knockout of PA200 improves proteasomal degradation and myelination in a proteotoxic neuropathy. Life science alliance 7 (4) (2024)
Jordan J S VerPlank, Joseph M Gawron, Nicholas J Silvestri, Lawrence Wrabetz, Maria Laura Feltri
Knockout of PA200 improves proteasomal degradation and myelination in a proteotoxic neuropathy. Life science alliance 7 (4) (2024)
Jordan J S VerPlank, Joseph M Gawron, Nicholas J Silvestri, Lawrence Wrabetz, Maria Laura Feltri
Knockout of PA200 improves proteasomal degradation and myelination in a proteotoxic neuropathy. Life science alliance 7 (4) (2024)
Jordan J S VerPlank, Joseph M Gawron, Nicholas J Silvestri, Lawrence Wrabetz, Maria Laura Feltri
Knockout of PA200 improves proteasomal degradation and myelination in a proteotoxic neuropathy. Life science alliance 7 (4) (2024)
Jordan J S VerPlank, Sylwia D Tyrkalska, Angeleen Fleming, David C Rubinsztein, Alfred L Goldberg
cGMP via PKG activates 26S proteasomes and enhances degradation of proteins, including ones that cause neurodegenerative diseases. Proceedings of the National Academy of Sciences of the United States of America 117 (25) (2020)

Jordan J S VerPlank.css-eqlu8i{font-size:small;padding-left:4px;} (Jordan Js VerPlank)